Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07121907

Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Caranx Medical · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The TAVIPILOT Software by Caranx Medical is an advanced intraoperative assistance tool designed to enhance the accuracy of transcatheter aortic valve positioning during TAVI. It works alongside conventional fluoroscopy, using real-time image analysis to provide precise anatomical landmarks. TAVIPILOT Software detects key anatomical structures, tracks valve positioning, and uses AI-based confidence indicators to assist in alignment. The software is compatible with approved C-arm imaging systems and specific catheter models. The objective is to assess the feasibility and safety of the TAVIPILOT Software augmented reality guidance software during TAVI procedures, aiming to improve valve positioning precision and, implicitly and to reduce implantation depth variations.

Conditions

Interventions

TypeNameDescription
DEVICETAVR using a guidance softwareTAVR procedure with TAVIPILOT augmented reality guidance software operating during the procedure, enabling clinicians to assess the live analysis and recommendations provided by the software.

Timeline

Start date
2025-09-15
Primary completion
2025-11-15
Completion
2026-02-15
First posted
2025-08-14
Last updated
2025-08-14

Regulatory

Source: ClinicalTrials.gov record NCT07121907. Inclusion in this directory is not an endorsement.